Nuevo Therapeutics Private Limited

Nuevo Therapeutics Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24232TG2013PTC085338 Incorporated 10 January 2013 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.11 Cr
▲ 6.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
13 yrs
Est. 2013
Last financials
Mar 2025
Balance sheet date

About Nuevo Therapeutics Private Limited

Data last updated: 07 February 2026

Nuevo Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 10 January 2013, the company has been in operation for over 13 years.

Registered with ROC Hyderabad under CIN U24232TG2013PTC085338.

Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Priyatham Reddy Chennareddy and Geetha Reddy Channa.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: M. No. 8 – 2 – 502/1/A Jivi Towers Road No. 7 Banjara Hills, Hyderabad, Telangana, India – 500034.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.11 Cr, a growth of 6% compared to the previous year.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nuevo.co.in.

Company Details of Nuevo Therapeutics Private Limited
CIN U24232TG2013PTC085338
Registration Number 085338
Incorporation Date 10 January 2013
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    M. No. 8 – 2 – 502/1/A Jivi Towers Road No. 7 Banjara Hills, Hyderabad, Telangana, India – 500034
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Nuevo Therapeutics Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Nuevo Therapeutics Private Limited report

Financials, compliance, directors, charges, ownership and filings for Nuevo Therapeutics Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Nuevo Therapeutics Private Limited

Nuevo Therapeutics Private Limited has one previous CIN (Corporate Identification Number): U24232AP2013PTC085338. The current CIN is U24232TG2013PTC085338, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24232TG2013PTC085338 Current
U24232AP2013PTC085338 Previous

Business Activity of Nuevo Therapeutics Private Limited

Nuevo Therapeutics Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Nuevo Therapeutics Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Nuevo Therapeutics Private Limited

Nuevo Therapeutics Private Limited is audited by B R R & ASSOCIATES for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
B R R & ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Nuevo Therapeutics Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Nuevo Therapeutics Private Limited

Nuevo Therapeutics Private Limited is governed by 3 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Priyatham Reddy Chennareddy Director 10 Jan 2013 13 Years 7 Months Current
Geetha Reddy Channa Director 10 Jan 2013 13 Years 7 Months Current
Mitra Puchhalapalli Director 10 Jan 2013 13 Years 7 Months Current

Financials of Nuevo Therapeutics Private Limited FY 2025 filings available

Nuevo Therapeutics Private Limited reported revenue of ₹1.11 Cr (up 6.00% YoY) for FY 2025.

Revenue · FY 2025
₹1.11 Cr ▲ 6.00%
Premium access

Ten-year financial statements for Nuevo Therapeutics Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Nuevo Therapeutics Private Limited

Premium access

Shareholding and ownership data for Nuevo Therapeutics Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Nuevo Therapeutics Private Limited

Nuevo Therapeutics Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Nuevo Therapeutics Private Limited

View historical data on people associated with Nuevo Therapeutics Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Nuevo Therapeutics Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Nuevo Therapeutics Private Limited

Premium access

GST registrations and filing compliance for Nuevo Therapeutics Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Nuevo Therapeutics Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Nuevo Therapeutics Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Nuevo Therapeutics Private Limited

Premium access

MSME payment history for Nuevo Therapeutics Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Nuevo Therapeutics Private Limited

Premium access

Corporate group structure for Nuevo Therapeutics Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Nuevo Therapeutics Private Limited

Premium access

MCA filings and documents for Nuevo Therapeutics Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Nuevo Therapeutics Private Limited

Activity
30 Sep 2025
Nuevo Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Nuevo Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
10 Jan 2013
Priyatham Reddy Chennareddy was appointed as a Director on 10 Jan 2013 & has been associated with this company since 13 years 7 months.
Directors
10 Jan 2013
Geetha Reddy Channa was appointed as a Director on 10 Jan 2013 & has been associated with this company since 13 years 7 months.
Directors
10 Jan 2013
Mitra Puchhalapalli was appointed as a Director on 10 Jan 2013 & has been associated with this company since 13 years 7 months.
Activity
10 Jan 2013
Nuevo Therapeutics Private Limited was registered on 10 Jan 2013 with Roc Hyderabad & aged 13 years 7 months as per MCA records.

Frequently Asked Questions about Nuevo Therapeutics Private Limited

Nuevo Therapeutics Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 10 January 2013 (13+ years old) and is registered under CIN U24232TG2013PTC085338.

Nuevo Therapeutics Private Limited reported revenue of ₹1.11 Cr for FY 2025 (up 6.00% YoY).

The current directors of Nuevo Therapeutics Private Limited are:

The primary industry of Nuevo Therapeutics Private Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.

Nuevo Therapeutics Private Limited can be reached at the registered office: M. No. 8 – 2 – 5021A Jivi Towers Road No. 7 Banjara Hills, Hyderabad, Telangana, India – 500034, or through the website nuevo.co.in.

The authorised capital is ₹1 Lakh, and the paid-up capital is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available